Earnings Call · Q4 FY2025·2026-02-24

Q4 25EPS +3.85%·Rev n/aQ3 25EPS +3.14%·Rev n/aQ2 25EPS +16.42%·Rev n/aQ1 25EPS 0.00%·Rev n/a⚠ consensus missing

CYTOKINETICS INC CYTK

Diane Weiser — Investor Relations

Robert I. Blum — President and Chief Executive Officer

Andrew M. Callos — Executive Vice President and Chief Commercial Officer

Fady Malik — Head of Medical Affairs

Stuart Kupfer — Head of Clinical Development

Sung H. Lee — Chief Financial Officer

−10.3%1d on move date−11.1% vs SPY3d−11.2%5d−13.4%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CYTK calls or request research access.

More CYTK calls Browse calls Request research access